Loading...

Suvinil Acquisition And Expansion Will Strain Margins Yet Offer Upside

Published
09 Apr 25
Updated
07 May 25
AnalystLowTarget's Fair Value
US$278.38
29.4% overvalued intrinsic discount
16 Jul
US$360.10
Loading
1Y
-4.1%
7D
-3.3%

Author's Valuation

US$278.4

29.4% overvalued intrinsic discount

AnalystLowTarget Fair Value

Shared on07 May 25
Fair value Decreased 14%

AnalystLowTarget has decreased future PE multiple from 29.9x to 25.6x.

Shared on30 Apr 25
Fair value Increased 16%

AnalystLowTarget has increased revenue growth from 2.0% to 2.3%.

Shared on16 Apr 25
Fair value Decreased 14%